Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome

Clinica Chimica Acta

Volumn 383, Issue 1-2, 2007, Pages 126-132

  Hallikainen, Maarit ^a   Kolehmainen, Marjukka ^a   Schwab, Ursula ^a,b   Laaksonen, David E ^a,b   Niskanen, Leo ^b   Rauramaa, Rainer ^a,b   Pihlajamäki, Jussi ^b   Uusitupa, Matti ^a   Miettinen, Tatu A ^c   Gylling, Helena ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adiponectin; C reactive protein; Cholestanol; Cholesterol metabolism; Desmosterol; Leptin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTANOL; CHOLESTEROL; DESMOSTEROL; GLUCOSE; INTERLEUKIN 6; LEPTIN; PHYTOSTEROL; SITOSTEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL;

EID: 34347339448     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.05.006     Document Type: Article

References (38)

1. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
2. Chan D.C., Watts G.F., Barrett P.H., et al. Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. Clin Sci 104 (2003) 383-388
3. Gylling H., Hallikainen M., Kolehmainen M., et al. Cholesterol synthesis prevails over absorption in metabolic syndrome. Trans Res 149 (2007) 310-316
4. Rabin K.R., Kamari Y., Avni I., Grossman E., and Sharabi Y. Adiponectin: linking the metabolic syndrome to its cardiovascular consequences. Expert Rev Cardiovasc Ther 3 (2005) 465-471
5. Trujillo M.E., and Scherer P.E. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257 (2005) 167-175
6. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose- specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
7. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
8. Kantartzis K., Rittig K., Balletshofer B., et al. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 52 (2006) 1934-1942
9. Havel P.J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13 (2002) 51-59
10. Meier U., and Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50 (2004) 1511-1525
11. Kougias P., Chai H., Lin P.H., et al. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 126 (2005) 121-129
12. Sinha M.K., Opentanova I., Ohannesian J.P., et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 98 (1996) 1277-1282
13. Park K.G., Park K.S., Kim M.J., et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 63 (2004) 135-142
14. Chait A., Han C.Y., Oram J.F., and Heinecke J.W. Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?. J Lipid Res 46 (2005) 389-403
15. Laaksonen D.E., Niskanen L., Nyyssönen K., et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47 (2004) 1403-1410
16. Niskanen L., Laaksonen D.E., Nyyssönen K., et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 44 (2004) 859-865
17. Dvoráková-Lorenzová A., Suchánek P., Havel P.J., et al. The decrease in C- reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55 (2006) 359-365
18. Ruan H., Miles P.D., Ladd C.M., et al. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-α: implications for insulin resistance. Diabetes 51 (2002) 3176-3188
19. Pi-Sunyer F.X. The relation of adipose tissue to cardiometabolic risk. Clin Cornerstone 8 Suppl 4 (2006) S14-S23
20. Kahn S.E., Zinman B., Haffner S.M., et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55 (2006) 2357-2364
21. Salas-Salvado J., Bullo M., Garcia-Lorda P., et al. Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss. Int J Obes Relat Metab Disord 30 (2006) 1714-1720
22. National Cholesterol Education Program. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
23. Grundy S.M. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47 (2006) 1093-1100
24. Sarkkinen E., Schwab U., Niskanen L., et al. The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. Eur J Clin Nutr 50 (1996) 592-598
25. Boston R.C., Stefanovski D., Moate P.J., et al. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 5 (2003) 1003-1015
26. Miettinen T.A., Tilvis R.S., and Kesäniemi Y.A. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 38 (1989) 136-140
27. Miettinen T.A., Tilvis R.S., and Kesäniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131 (1990) 20-31
28. Miettinen T.A. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 29 (1988) 43-51
29. Rastas M., Seppänen R., Knuts L.-R., Karvetti R.-L., and Varo P. Nutrient composition of foods (1993), Publications of the Social Insurance Institution, Helsinki
30. Pihlajamäki J., Gylling H., Miettinen T.A., and Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 45 (2004) 507-517
31. Simonen P., Gylling H., Howard A.N., and Miettinen T.A. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 72 (2000) 82-88
32. Miettinen T.A., and Gylling H. Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 153 (2000) 241-248
33. Simonen P.P., Gylling H.K., and Miettinen T.A. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 25 (2002) 1511-1515
34. Simonen P.P., Gylling H., and Miettinen T.A. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes Res 10 (2002) 328-335
35. Abdul-Ghani M.A., Matsuda M., Balas B., and DeFronzo R.A. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30 (2007) 89-94
36. Peltola P., Pihlajamäki J., Koutnikova H., et al. Visceral obesity is associated with high levels of serum squalene. Obes 14 (2006) 1155-1163
37. Gylling H. Cholesterol metabolism and its implications for therapeutic interventions in patients with hypercholesterolaemia. Int J Clin Pract 58 (2004) 859-866
38. Yki-Järvinen H. Fat in the liver and insulin resistance. Ann Med 37 (2005) 347-356